university-spinout · medical-implant · neurostimulation
INBRAIN Neuroelectronics
Graphene neural interfaces for therapy.
Barcelona graphene-electrode neuroscience startup. Developing high-density cortical electrode arrays for closed-loop neurological-disease therapy and intraoperative brain mapping. First-in-human surgical use 2024.
At a glance
- Legal name
- INBRAIN Neuroelectronics S.L.
- Aliases
- —
- Type
- university-spinout
- Focus areas
- medical-implant, neurostimulation, therapeutic, brain-mapping
- Founded
- Defunct
- —
- Spinout of
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)
- HQ city
- Barcelona
- HQ country
- ES
- Employees
- 51-200
- Flagship device
- inbrain-graphene-bci
- Product lines
- 1
- In-house manufacturing
- Yes
- Open source
- —
- GitHub org
- —
- Website
- inbrain-neuroelectronics.com
- Blog
- —
- Support
- —
Devices
People
Founders
Carolina Aguilar
Co-Founder, CEO
Jose A. Garrido
Co-Founder, Chief Scientific Officer
Current leadership
Carolina Aguilar
CEO
Funding
- Stage
- series-b
- Total raised
- EUR 67,000,000
| Stage | Date | Amount | Lead investors |
|---|---|---|---|
| series-a | — | — | |
| series-b | — | Asabys Partners |
Milestones
Spun out of ICN2 Barcelona
FDA Breakthrough Device designation
First-in-human implant
Used intraoperatively during glioma resection at Salford Royal NHS Foundation Trust (UK).
Reputation
Highest-profile graphene-cortical-interface program globally. Combines novel materials with a closed-loop therapy strategy targeting Parkinson's and intraoperative brain mapping.